Phase II study with a new alkylating agent (PTT-119) in lymphoid malignancies

Haematologica. 1988 Nov-Dec;73(6):503-8.
No abstract available

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adult
  • Aged
  • Aged, 80 and over
  • Antineoplastic Agents / adverse effects
  • Antineoplastic Agents / therapeutic use*
  • Drug Evaluation
  • Female
  • Humans
  • Lymphoproliferative Disorders / drug therapy*
  • Male
  • Middle Aged
  • Nitrogen Mustard Compounds / adverse effects
  • Nitrogen Mustard Compounds / therapeutic use*

Substances

  • Antineoplastic Agents
  • Nitrogen Mustard Compounds
  • ambamustine